top of page

PROMETEO THERAPEUTICS

Prometeo is developing a drug design and synthesis platform to advance clinical compounds against several kinase targets that have critical roles in regulating inflammatory pathways and are strongly implicated in anti-viral and anti-tumor immune response.  

Home: Welcome
_edited.jpg

OUR INNOVATIVE APPROACH

At Prometeo therapeutics, we make existing small molecules better, and use a modular design approach to generate novel and enhanced libraries of compounds, including close structural analogs, to provide extensive structure-activity relationship (SAR) analysis. We then use innovative isogenic and patient derived 3D organoids platforms to select our enhanced small molecule candidates.

Home: About Us

Thanks for submitting!

Home: Contact

Subscribe Form

Thanks for submitting!

  • Facebook
  • Twitter
  • LinkedIn
bottom of page